Delivery Order SPE2DB20D3103-SPE2DB24FL6D9
- Not listed
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a medication used to treat respiratory conditions. The contract has a firm fixed price of $1,563.91 and a completion date of May 5, 2025. The award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,772,504 units of budesonide-formoterol 160-4.5 10.2GM, a medication used for the treatment of respiratory conditions. The delivery order is valued at $2,620.80 and has a firm fixed price pricing type. The contract has an ultimate completion date of April 3, 2025 and was...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a medication, with a ceiling value of $3,264.95 and a period of performance through December 30, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,088.44 firm fixed-price contract is for the supply of 4565047394 Budesonide-Formoterol 160-4.5 10.2GM, a medical product used in the treatment of respiratory conditions. The contract has an ultimate completion date of July 2, 2024 and was awarded on July 1, 2024. This delivery order is part of a larger Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a medication used to treat respiratory conditions. The contract has a firm fixed price of $2,240.74 and a completion date of April 23, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for 4,568,062,481 units of the medication Budesonide-Formoterol 160-4.5 10.2GM. The contract is a firm fixed-price delivery order with a ceiling value of $1,747.20 and a period of performance through April 29, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a medication used to treat respiratory conditions. The contract has a firm fixed price with a ceiling value of $1,191.18 and a period of performance ending on May 16, 2025. This contract is not set aside and represents open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,455.63, is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of January 31, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,399.56 contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a medication used for the treatment of respiratory conditions. The contract has a period of performance through December 11, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,205.56 firm fixed-price delivery order is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a medication used to treat respiratory conditions. The contract has an ultimate completion date of April 11, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FL6D9Delivery Order
This is a federal delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a medication used for the treatment of respiratory conditions. The contract has a ceiling value of $3,625.98 and an ultimate completion date of November 22, 2023. This contract is a firm fixed-price delivery order placed under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 11/21/23 |